---
figid: PMC8750348__cancers-14-00087-g005
figtitle: FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
organisms:
- NA
pmcid: PMC8750348
filename: cancers-14-00087-g005.jpg
figlink: /pmc/articles/PMC8750348/figure/cancers-14-00087-f005/
number: F5
caption: 'Glasdegib inhibition of the Hedgehog signaling pathway. HH: Hedgehog. PTCH:
  Patched receptor. SMO: smoothened receptor. SUFU: suppressor of fused protein. GLI:
  glioma-associated oncogene protein. GLIr: repressor form of GLI. Created with BioRender.com
  based on information in [].'
papertitle: FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review.
reftext: Aleksandra Sochacka-Ćwikła, et al. Cancers (Basel). 2022 Jan;14(1):87.
year: '2022'
doi: 10.3390/cancers14010087
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: small molecule agents | macromolecule agents | hematological malignancies
  | FDA | EMA
automl_pathway: 0.9521109
figid_alias: PMC8750348__F5
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8750348__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8750348__cancers-14-00087-g005.html
  '@type': Dataset
  description: 'Glasdegib inhibition of the Hedgehog signaling pathway. HH: Hedgehog.
    PTCH: Patched receptor. SMO: smoothened receptor. SUFU: suppressor of fused protein.
    GLI: glioma-associated oncogene protein. GLIr: repressor form of GLI. Created
    with BioRender.com based on information in [].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hh
  - ptc
  - 'Off'
  - smo
  - sm
  - ix
  - Su(fu)
  - Gli
  - ci
---
